Skip to main content

       What I Lead


  • Enterprise transformation from strategy through execution
  • M&A integration: IMO leadership from pre-deal through value capture
  • New platforms and business models: launches in research and regulated life science markets
  • Portfolio acceleration: roadmap alignment, commercial adoption, and AI-powered operating decisions
  • Technology deployment: LIMS, innovation management, and PM platforms across global operations


ABOUT

Execution

beats strategy.

Every time.

Lesson learned from 20 years at the intersection of life science R&D, commercial, and operations.


I've built and led innovation in biologics, cell & gene therapy, and research tools at Sartorius and MilliporeSigma managing global portfolios spanning instruments, consumables, and software across 150+ products, $600M in revenue impact, and 30% SAM expansion through organic and inorganic growth. I've owned P&L decisions where science, commercial, and operations moved as one and have seen what happens when they diverge. 


I translate science and technology value into commercial and operational realities.


Lean Six Sigma Black Belt, PMP, MBA, Harvard Business School.




Science creates

the opportunity.

I help you capture it.

WHY ME

I've worked in and led across the full innovation journey and have seen how compounding decisions across functions create interdependencies that kill deals, derail launches, erode profits.



HOW I WORK

There is always

a path forward.

Whether you are a fund, a portfolio company, or a life science operator.  


Strategy fails without disciplined execution.  

Poor execution creates bad strategy. 

Start with the right bet.




For M&A, I run the IMO. Three levers, every time.


1. Operational fit


2. Technical compatibility


3. Cultural alignment


Deal thesis, operating strategy, and leadership aligned from pre-deal through Day 1 and integration.